Holen Sie sich die Stockscreener-App
14.54
0.52%
0.07
Schlusskurs vom Vortag:
$14.47
Offen:
$14.56
24-Stunden-Volumen:
33,764
Relative Volume:
0.07
Marktkapitalisierung:
$671.65M
Einnahmen:
$681.50M
Nettoeinkommen (Verlust:
$15.70M
KGV:
42.76
EPS:
0.34
Netto-Cashflow:
$36.60M
1W Leistung:
-4.56%
1M Leistung:
-12.22%
6M Leistung:
-39.39%
1J Leistung:
-23.36%
1-Tages-Spanne:
$14.48
$14.65
1-Wochen-Bereich:
$14.25
$15.50
52-Wochen-Spanne:
$14.25
$25.36
Avanos Medical Inc Stock (AVNS) Company Profile
Firmenname
Avanos Medical Inc
Sektor
Branche
Telefon
844-428-2667
Adresse
5405 WINDWARD PARKWAY, ALPHARETTA, GA
Vergleichen Sie AVNS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVNS
Avanos Medical Inc
|
14.54 | 671.65M | 681.50M | 15.70M | 36.60M | 0.34 |
|
ABT
Abbott Laboratories
|
126.18 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
97.13 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
370.29 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.11 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.74 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Avanos Medical Inc Stock (AVNS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-07-25 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-22 | Eingeleitet | CL King | Buy |
| 2021-08-04 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-04-13 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-11-07 | Herabstufung | Stifel | Buy → Hold |
| 2019-11-06 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2018-10-16 | Eingeleitet | Barclays | Equal Weight |
| 2018-08-21 | Hochstufung | Raymond James | Mkt Perform → Outperform |
Alle ansehen
Avanos Medical Inc Aktie (AVNS) Neueste Nachrichten
Avanos Medical (NYSE:AVNS) Rating Lowered to Hold at StockNews.com - Defense World
Don't Ignore The Insider Selling In Avanos Medical - Simply Wall St
Do Options Traders Know Something About Avanos (AVNS) Stock We Don't? - Nasdaq
Top Executive Sells Thousands of Avanos Medical Shares! - TipRanks
Avanos Medical’s SVP Holbrook Kerr sells $106,778 in stock By Investing.com - Investing.com Australia
Avanos Medical’s SVP Holbrook Kerr sells $106,778 in stock - Investing.com India
How to Take Advantage of moves in (AVNS) - Stock Traders Daily
Principal Financial Group Inc. Acquires 7,932 Shares of Avanos Medical, Inc. (NYSE:AVNS) - Defense World
Avanos Medical, Inc. (NYSE:AVNS) Stake Lowered by Rhumbline Advisers - Defense World
Avanos Medical (NYSE:AVNS) Hits New 1-Year LowTime to Sell? - MarketBeat
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates - MSN
Avanos Medical (NYSE:AVNS) Releases FY 2025 Earnings Guidance - MarketBeat
Avanos Medical: Hold Rating Amidst Transformational Challenges and Market Uncertainties - TipRanks
Avanos Medical’s Earnings Call: Mixed Sentiments and 2025 Outlook - TipRanks
Avanos Medical (NYSE:AVNS) Releases Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract - Yahoo Finance
Avanos Medical, Inc. (NYSE:AVNS) Q4 2024 Earnings Call Transcript - Insider Monkey
Avanos Medical Q4 2024 sales up 3.6% to USD 179.6 million - Medical Buyer
Avanos Medical’s Rollercoaster: Strong Growth Amidst Market Headwinds - MotoPaddock
Avanos Medical Inc (AVNS) Q4 2024 Earnings Call Highlights: Strong Organic Growth Amidst ... - Yahoo Finance
Avanos Medical Reports 2024 Financial Results - TipRanks
AVANOS MEDICAL, INC. SEC 10-K Report - TradingView
Avanos Medical Inc Reports Q4 Revenue of $179.6M, Beating Estima - GuruFocus.com
Avanos Medical: Balancing Strong Q4 Performance with Strategic Challenges – Hold Rating Maintained - TipRanks
Avanos price target lowered to $17 from $20 at Stifel - TipRanks
Avanos Medical rises on Q4 sales beat - TradingView
Earnings call transcript: Avanos Medical Q4 2024 beats expectations - Investing.com
Avanos Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Avanos Medical: Q4 Earnings Snapshot - San Antonio Express-News
AVANOS MEDICAL Earnings Results: $AVNS Reports Quarterly Earnings - Nasdaq
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results - TradingView
Avanos Medical earnings beat by $0.03, revenue topped estimates - Investing.com UK
BRIEF-Avanos Medical Q4 Sales USD 179.6 Million - TradingView
Avanos Medical Inc expected to post earnings of 40 cents a shareEarnings Preview - TradingView
Avanos Medical, Inc. (NYSE:AVNS) Shares Bought by New York State Teachers Retirement System - Defense World
Avanos Medical (AVNS) to Release Earnings on Wednesday - Defense World
Paradice Investment Management LLC Buys 30,949 Shares of Avanos Medical, Inc. (NYSE:AVNS) - MarketBeat
Avanos Medical (NYSE:AVNS) Trading Down 6.3%Here's What Happened - MarketBeat
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results - cnhinews.com
62,129 Shares in Avanos Medical, Inc. (NYSE:AVNS) Bought by Rice Hall James & Associates LLC - MarketBeat
Can Avanos Medical's Q4 Earnings Call Reveal Its Post-Leadership Change Strategy? - StockTitan
Empowered Funds LLC Acquires 90,091 Shares of Avanos Medical, Inc. (NYSE:AVNS) - MarketBeat
Avanos Medical, Inc. (NYSE:AVNS) Sees Large Decline in Short Interest - Defense World
Urea Breath Test Market Growth in Future Scope 2025-2032 | Avanos Medical, Inc.,Quest Diagnostics, Paladin Labs Inc. - openPR
Reasons to Hold Avanos Medical Stock in Your Portfolio Now - MSN
Avanos Medical (AVNS) Expected to Announce Quarterly Earnings on Tuesday - Defense World
(AVNS) Technical Pivots with Risk Controls - Stock Traders Daily
Avanos Medical (AVNS) Projected to Post Earnings on Tuesday - MarketBeat
USFDA Identifies Recall Of Avanos Medical's Respiratory Systems As Most Serious - BW Healthcare World
Avanos Medical, Inc. (NYSE:AVNS) Short Interest Update - MarketBeat
Radiofrequency Ablation Devices For Pain Management Market - openPR
Finanzdaten der Avanos Medical Inc-Aktie (AVNS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.57%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):